About Adele

Adele S. Benzaken is the Director for STI, HIV/Aids and Viral Hepatitis Department of the Ministry of Health of Brazil, she works primarily in the field of STI prevention, control and treatment, being a permanent consultant of PAHO as well.

Adele S. Benzaken graduated in Medicine from the Federal University of Amazonas (1978). Made her residency (1980) and expertise (1985) in Gynecology. PhD in Public Health at the Oswaldo Cruz Foundation (CPqL & MD / Manaus). She was also a director of Tropical Dermatology and Venereology Foundation Alfredo da Matta in Manaus, Amazonas, in the period from 2007 to 2010. Member of the Expert Panel on STIs including HIV, World Health Organization (WHO) from December 2008 to July 2013. Official Program office of the UNAIDS / Brazil in Brasilia from April 2012 to November 2013 and currently Director of the Department of STI / AIDS and Viral Hepatitis of the Ministry of Health of Brazil. She is also an Advisor of the Pan American Health Organization (PAHO) and is a Vice-Chairman of the Committee for Validation of Elimination of Vertical Transmission of HIV and Congenital Syphilis in Latin America and the Caribbean, hosted by PAHO. Dr. Adele Benzaken works primarily with STI and Aids assistance, prevention and control.

This speaker will be presenting at the following session(s)

  • Strategic direction 2: interventions for impact and strategic direction 3: delivering for equity

    Golden Hall

    Day: 2 November

    Time: 09:15

    The second day of the Summit is dedicated to strategic directions 2 and 3, which cover the issues of "interventions for impact" and "delivering for equity".

    Chairs: Dr. Florence Zeh Kakanou, Ministry of Public Health, Cameroon and Dr. Saeed Hamid, The Aga Khan University, Pakistan

    Presentations:

    • 5 core interventions to reach HBV and HCV elimination.
      Dr. Hande Harmanci, World Health Organization
    • Scaling-up of treatment services in Brazil.
      Dr. Adele Benzaken, Ministry of Health, Brazil
    • Hepatitis B services – challenges and opportunities.
      Dr. Chukwuma Anyaike, Federal Ministry of Health, Nigeria
    • Continuum of interventions to prevent HBV infection at birth and in the first years of life
    • Dr. John Ward, US Centers for Disease Control and Prevention
    • Hepatitis C prevention and treatment for PWID.
      Prof. Gregory Dore, Kirby Institute, UNSW Sydney and St Vincent’s Hospital, Sydney
    • Hepatitis services for indigenous people.
      Luana Silveira de Faria, Ministry of Health, Brazil
    • Q & A session.

    Session objectives:

    • Learn areas of innovation and neglected issues.
    • Hear about the core issues for elimination and equitable access.
    • Gain an overview of the main advocacy areas and gaps.